iPACK and Femoral Triangle Block for Pain Control in ACL Reconstruction
Analgesic Efficacy and Functional Recovery of Adding iPACK to Femoral Triangle Block in Anterior Cruciate Ligament Reconstruction
The goal of this clinical trial is to learn if adding an iPACK block (a nerve block for the back of the knee) to a femoral triangle block improves pain control and knee function after surgery in adults aged 18 to 50 years undergoing anterior cruciate ligament (ACL) reconstruction. It will also learn about the safety of the combined blocks. The main questions it aims to answer are:
Does adding an iPACK block to a femoral triangle block lower postoperative pain scores over the first 48 hours? Does the combined block reduce the amount of opioid pain medication needed and delay the time to first rescue pain medication? Does the combined block improve early knee function (quadriceps strength, knee range of motion, and patient-reported knee scores) without causing muscle weakness or other complications?
Researchers will compare a femoral triangle block plus an iPACK block to a femoral triangle block alone (with a sham procedure to keep patients unaware of their group) to see if the added iPACK block provides better pain relief and recovery after ACL reconstruction.
Participants will:
Receive either a femoral triangle block plus an iPACK block, or a femoral triangle block alone, under ultrasound guidance before or after surgery Rate their pain at rest and during movement at 6, 12, 24, and 48 hours after surgery Have their pain medication use, quadriceps strength, knee movement, and time to first walking recorded during the hospital stay Complete knee function questionnaires (IKDC, Lysholm, and KOOS) before surgery and at follow-up visits at 2 weeks, 6 weeks, and 3 months Be monitored for side effects such as nausea, vomiting, falls, and nerve-related problems
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Quetta, Pakistan
- Cmh Quetta
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Adults aged 18 to 50 years, of either sex, Scheduled for primary, unilateral, elective arthroscopic anterior cruciate ligament (ACL) reconstruction (autograft, e.g., hamstring or patellar tendon),American Society of Anesthesiologists (ASA) physical status I or II, Body mass index (BMI) of 35 kg/m² or less Planned spinal or general anesthesia Able to understand and use the Numeric Rating Scale (NRS) for pain, and able to comply with postoperative assessments and follow-up visits Willing and able to provide written informed consent
Exclusion Criteria:
- Patient refusal or inability to provide informed consent Known allergy or hypersensitivity to local anesthetics or other study medications Coagulopathy, or use of anticoagulants or antiplatelet agents that contraindicate regional anesthesia Infection at the planned block injection site Pre-existing neurological deficit or neuropathy in the operative limb Revision ACL surgery, multiligament reconstruction, or major concomitant procedures (e.g., osteotomy, cartilage restoration) Chronic opioid use or chronic pain conditions Contraindication to paracetamol or NSAIDs that would prevent standardized multimodal analgesia Psychiatric or cognitive disorder that limits pain assessment Pregnancy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Group FTB
|
An ultrasound-guided femoral triangle block performed on the operative limb with the patient supine. A high-frequency linear transducer is placed transversely over the anterior thigh, below the inguinal crease, at the level where the sartorius muscle crosses the femoral artery and the femoral triangle is bordered by the sartorius, adductor longus, and inguinal ligament. A 22-gauge, 80 to 100 mm echogenic block needle is advanced in-plane, lateral to medial, to the lateral side of the femoral artery, beneath the fascia iliaca and above the iliopsoas muscle, and local anesthetic is deposited around the femoral artery to target the saphenous nerve, the nerve to the vastus medialis, and the anterior femoral cutaneous branches. |
|
Experimental: Group FTB with Ipack
|
An ultrasound-guided iPACK block performed in addition to the FTB, The patient is positioned supine with the knee flexed and hip externally rotated. A curvilinear or linear transducer is placed in the popliteal fossa at the level of the femoral condyles, and the popliteal artery and posterior surface of the femur are identified. A 22-gauge, 80 to 100 mm block needle is advanced in-plane from the medial side to the plane between the popliteal artery and the femoral shaft or condyles, posterior to the artery and anterior to the posterior knee capsule. After negative aspiration, 15 to 20 mL of the same local anesthetic is injected |
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
postoperative pain intensity at rest and on movement, measured by the Numeric Rating Scale (NRS, 0 to 10)
Time Frame: 6, 12, 24, and 48 hours after the end of surgery
|
6, 12, 24, and 48 hours after the end of surgery
|
|
Total opioid consumption
Time Frame: 48 hours after surgery
|
48 hours after surgery
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- ipack/2026
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.